Soroka Hospital and Ben Gurion University, Beer Sheva, Israel
13 April 2013
Attention deficit/hyperactivity disorder (ADHD) is a mental health disorder characterized by various symptoms including cognitive impairments, inattention, impulsivity and in some cases, hyperactivity. Despite its high prevalence, the only empirically validated treatment for ADHD is chronic administration of psychostimulants which is not tolerable by all patients. Brainsway Company operates a clinical study in Soroka medical center in cooperation with Ben-Gurion University which designed to investigate the therapeutic effect of Deep TMS - Transcranial Magnetic Stimulation - on attention measures of ADHD patients map the resulting short and long – term changes within the brain.
In this double-blind randomized controlled study, patients diagnosed as having adult ADHD receive 15 sessions of high-frequency Deep TMS - Transcranial Magnetic Stimulation - using either deep, standard or sham coils over the right prefrontal cortex. Assessments of the anticipated change includes behavioral measures and questionnaires, as well as electroencephalogram measurements operated during rest and an evoked response procedure using a stop signal task for evaluation of potential alterations in brain activity of the various treatment groups.
Contact: Hamutal Shahar +(972) 02-5824030, Hamutal@brainsway.com
Principal Investigator: Prof. Abraham Zangen and Dr. Nadav Shalev